Effect of Aliskiren on Post-Discharge Outcomes Among Diabetic and Non-Diabetic Patients Hospitalized for Heart Failure: Insights From the ASTRONAUT Trial

Study Questions:

What are differences in post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction receiving aliskiren, a direct renin inhibitor, with and without baseline diabetes mellitus?